CAS NO.:275371-94-3 Product Name:Taspoglutide Synonyms:Taspoglutide;Taspoglutide Acetate;BIM51077;ITM 077;R 1583;UNII-2PHK27IP3B;BIM 51077;RO 5073031;F85503;ITM077; R1583; BIM51077;275371-94-3;SCHEMBL2899791;DB14027;Taspoglutide trifluoroacetate salt EINECS: Molecular Formula:C152H232N40O45 Molecular Weight:3339.70947999999
Cat.No
DC22528
Name
Taspoglutide
Chemical Properties
CAS
275371-94-3
Formula
C152H232N40O45
MW
3339.70947999999
Storage
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
References
[1]. Sebokova E, et al. Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency. Endocrinology. 2010 Jun;151(6):2474-82.
[2]. Retterstol K, et al. Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue. Expert Opin Investig Drugs. 2009 Sep;18(9):1405-11.
[3]. Nauck MA, et al. Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study. Diabetes Care. 2009 Jul;32(7):1237-43.
[4]. Sebokova E, et al. Taspoglutide, a novel human once-weekly analogue of glucagon-like peptide-1, improves glucose homeostasis and body weight in the Zucker diabetic fatty rat. Diabetes Obes Metab. 2010 Aug;12(8):674-82.
[5]. Panjwani N, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology. 2013 Jan;154(1):127-39.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.